scholarly journals Preclinical evaluation of an 111In/225Ac theranostic targeting transformed MUC1 for triple negative breast cancer

Theranostics ◽  
2020 ◽  
Vol 10 (15) ◽  
pp. 6946-6958 ◽  
Author(s):  
Vanessa J Kelly ◽  
Shu-ta Wu ◽  
Vijay Gottumukkala ◽  
Richard Coelho ◽  
Keryn Palmer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Preclinical Evaluation

scholarly journals Preclinical Evaluation of Novel Pak4 Allosteric Modulators Against Triple Negative Breast Cancer

2014 ◽  
Vol 25 ◽  
pp. iv127
Author(s):  
W. Senapedis ◽  
D. McCauley ◽  
Y. Landesman ◽  
O. Kalid ◽  
J. Ellis ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Allosteric Modulators ◽  
Preclinical Evaluation

Abstract 1237: Preclinical evaluation of ERX-41 in triple negative breast cancer

2021 ◽  
Author(s):  
Suryavathi Viswanadhapalli ◽  
Xihui Liu ◽  
Shi-Hong Ma ◽  
Tae-Kyung Lee ◽  
Mengxing Li ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Preclinical Evaluation

scholarly journals Preclinical Evaluation of Mesothelin-Specific Ligands for SPECT Imaging of Triple-Negative Breast Cancer

2018 ◽  
Vol 59 (7) ◽  
pp. 1056-1062 ◽  
Author(s):  
Christopher Montemagno ◽  
Sandrine Bacot ◽  
Mitra Ahmadi ◽  
Brigitte Kerfelec ◽  
Daniel Baty ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Spect Imaging ◽  
Preclinical Evaluation

scholarly journals Preclinical evaluation targeting both IGF1R and IR in triple negative breast cancer

2019 ◽  
Vol 30 ◽  
pp. v782-v783
Author(s):  
A.J. Eustace ◽  
S. Roche ◽  
N. Mukherjee ◽  
F. O’Neill ◽  
N. Conlon ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Triple Negative Breast Cancer ◽  
Triple Negative ◽  
Preclinical Evaluation
Sign in / Sign up

Export Citation Format

Share Document